| 30.05 12:36 | dpa-AFX: *GOLDMAN STARTS ZIMMER BIOMET WITH 'NEUTRAL' - PRICE TARGET 129 USD |
| 30.05 12:36 | dpa-AFX: *GOLDMAN STARTET ZIMMER BIOMET MIT 'NEUTRAL' - ZIEL 129 USD |
| 30.05 04:53 | dpa-AFX: Zimmer Biomet To Repurchase Up To $2 Bln Of Common Stock |
| 29.05 18:03 | dpa-AFX: Zimmer Biomet Holdings 2024 Investor Day Webcast At 1:00 PM ET |
| 13.05 13:09 | dpa-AFX: *ZIMMER BIOMET ANNOUNCES Q2 CASH DIVIDEND OF $0.24/SHR; RECORD JUNE 26/PAYABLE ON OR ABOUT JULY 31 |
| 13.05 13:07 | dpa-AFX: *ZIMMER BIOMET HOLDINGS INC. (ZBH) DECLARES $ 0.24 DIVIDEND FOR Q2 24, RECORD DATE 6/26/2024 |
| 02.05 12:47 | dpa-AFX: Zimmer Biomet Holdings Inc. Q1 Profit Decreases, but beats estimates |
| 02.05 12:41 | dpa-AFX: *ZIMMER BIOMET CONTINUES TO EXPECT FY24 REPORTED REVENUE GROWTH OF 4.5% - 5.5% |
| 02.05 12:41 | dpa-AFX: *ZIMMER BIOMET CONTINUES TO EXPECT FY24 ADJ. EPS OF $8.00 - $8.15 |
| 02.05 12:39 | dpa-AFX: *ZIMMER BIOMET Q1 NET SALES $1.889 BLN VS. $1.831 BLN LAST YEAR |
| 02.05 12:38 | dpa-AFX: *ZIMMER BIOMET Q1 OPERATING PROFIT $265.9 MLN VS. $327.3 MLN LAST YEAR |
| 02.05 12:38 | dpa-AFX: *ZIMMER BIOMET Q1 NET INCOME $172.4 MLN VS. $232.5 MLN LAST YEAR |
| 02.05 12:33 | dpa-AFX: *ZIMMER BIOMET Q1 EPS $0.84 VS. $1.11 LAST YEAR |
| 22.02 13:48 | dpa-AFX: Zimmer Biomet Receives FDA's 510(k) Clearance For ROSA Shoulder System |
| 22.02 13:39 | dpa-AFX: *ZIMMER BIOMET RECEIVES FDA CLEARANCE FOR ROSA SHOULDER SYSTEM |
| 21.02 13:04 | dpa-AFX: *ZIMMER BIOMET DECLARES QUARTERLY CASH DIVIDEND OF $0.24/SHR; RECORD MAR 29/PAYABLE ON OR ABOUT APRIL 30 |
| 21.02 13:01 | dpa-AFX: *ZIMMER BIOMET HOLDINGS INC. (ZBH) DECLARES $ 0.24 DIVIDEND FOR Q1 24, RECORD DATE 3/29/2024 |
| 12.02 13:32 | dpa-AFX: *ZIMMER BIOMET SIGNS GLOBAL HEALTH EQUITY NETWORK'S ZERO HEALTH GAPS PLEDGE |
| 08.02 13:34 | dpa-AFX: Zimmer Biomet Holdings Q4 23 Earnings Conference Call At 8:30 AM ET |
| 08.02 12:41 | dpa-AFX: ROUNDUP: Zimmer Biomet Guides FY24 Above Estimates |
|
|
